Zum Inhalt

Pediatric Rheumatology

Ausgabe Sonderheft 1/2011 Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress

Inhalt (360 Artikel)

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile

  • Open Access
  • Oral presentation

AM Pesenacker, Stavroula Zavitsanou, Kiran Nistala, Lucy R Wedderburn

CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis

  • Open Access
  • Oral presentation

Yvonne Vercoulen, Elisabeth F Elst, Jenny Meerding, Maud Plantinga, Hemlata Varsani, Christa van Schieveen, Mette H Bakker, Mark Klein, Wim Spliet, R de Weger, Lucy Wedderburn, Annet van Royen-Kerkhof, Berent J Prakken

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus

  • Open Access
  • Oral presentation

Kim Ohl, Ralph Lippe, Eva Verjans, Nora Honke, Karin Maschke-Neuss, Norbert Wagner, Johannes Roth, Klaus Tenbrock

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

  • Open Access
  • Oral presentation

Pieter E H Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia M F Pluijm, Robert de Jonge

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

  • Open Access
  • Oral presentation

Sergio Davì, Bianca Lattanzi, Silvia Rosina, Erkan Demirkaya, Nicolino Ruperto, Alberto Martini, Randy Q Cron, Angelo Ravelli

Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis

  • Open Access
  • Oral presentation

SJ Vastert, W De Jager, BJ Noordman, D Holzinger, W Kuis, BJ Prakken, NM Wulffraat

Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells

  • Open Access
  • Oral presentation

EJ Wehrens, G Mijnheer, B Vastert, M Klein, J van Loosdregt, W de Jager, PJ Coffer, BJ Prakken, F van Wijk

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate

  • Open Access
  • Oral presentation

S Ursu, H Moncrieffe, H Varsani, RHB Hamaoui, L Beard, L Kassoumeri, F Patrick, LR Wedderburn

Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism

  • Open Access
  • Oral presentation

G Minnone, R Strippoli, G Prencipe, L De Pasquale, C Bracaglia, A Insalaco, F De Benedetti, L Bracci-Laudiero

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study

  • Open Access
  • Oral presentation

H Moncrieffe, D Holzinger, S Ursu, F Patrick, L Kassoumeri, J Roth, LR Wedderburn

Comparison of CNS vasculitis in children and adults; is this the same disease entity

  • Open Access
  • Oral presentation

Marinka Twilt, Carlo Salvarani, Tania Cellucci, Gene Hunder, Susanne Benseler

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?

  • Open Access
  • Oral presentation

C Malattia, A Consolaro, S Pederzoli, MB Damasio, R Hasija, M Mazzoni, A Madeo, A Beltramo, S Viola, A Buoncompagni, C Mattiuz, A Ravelli, A Martini

Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease

  • Open Access
  • Oral presentation

Rolando Cimaz, Giuliana Guggino, Salvatore Accomando, Gabriele Simonini, Ilaria Pagnini, Eiji Ohtsu, Tomisaku Kawasaki, Francesco Dieli, Mahavir Singh, Guido Sireci

Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender

  • Open Access
  • Oral presentation

S Venkatesan, NG Lawrence, C Carbone, E Jaeggi, ED Silverman, S Kamphuis

Preliminary validation of the paediatric vasculitis activity score (PVAS)

  • Open Access
  • Oral presentation

Fiona E Price-Kuehne, Despina Eleftheriou, Seza Ozen, Michael Beresford, Pavla Dolezalova, Paul A Brogan

Long-term methotrexate efficacy in juvenile localized scleroderma

  • Open Access
  • Oral presentation

F Zulian, C Vallongo, F Vittadello, G Zanon, S Giuliotto, G Martini

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)

  • Open Access
  • Oral presentation

Rina Mina, Laura Schanberg, Anne B Eberhard, Marisa Klein–Gitelman, Gloria Higgins, Karen Onel, Nora G Singer, Kathleen O’Neil, Lori Tucker, Deborah Levy, Wajeeha Yousaf, Shannen Nelson, Michael Beresford, Ruben Cuttica, Graciela Espada, Angelo Ravelli, Alberto Martini, Edward Giannini, Hermine I Brunner

Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus

  • Open Access
  • Oral presentation

NC Mak, C Carbone, LS Lim, DM Levy, ED Silverman, S Kamphuis

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus

  • Open Access
  • Oral presentation

Nur Canpolat, Ozgur Kasapcopur, Salim Caliskan, Selman Gokalp, Meltem Bor, Mehmet Tasdemir, Lale Sever, Nil Arisoy

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

  • Open Access
  • Oral presentation

N Ruperto, H Brunner, G Horneff, P Quartier, T Constantin, Y Berkun, M Erguven, T Kallinich, R Brik, NM Wulffraat, MA Ferrandiz, L Rutkowska-Sak, H Ozdogan, L McCann, K Lheritier, R Preiss, L Tseng, A Martini, DJ Lovell

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers

  • Open Access
  • Oral presentation

M Bertamino, A Consolaro, B Lattanzi, S Magni-Manzoni, S Lanni, C Suffia, S Dalprà, S Rosina, A Martini, A Ravelli

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

  • Open Access
  • Oral presentation

M Verkaaik, M Bulatović, G Sinnema, C Rademaker, NM Wulffraat

To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management

  • Open Access
  • Oral presentation

J Jones, J Munro, T Williams, A Augustine, K Taylor, S Piper, R Allen, J Akikusa

Identification of Blau Syndrome disease signatures

  • Open Access
  • Oral presentation

KP Foley, L Wang, D Cooper, M Magid-Slav, D Lipshutz, J Connor, M Miller, B Votta, P Gough, X Valencia, CH Wouters, CD Rosé, J Bertin

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

  • Open Access
  • Oral presentation

N Ruperto, DJ Lovell, A Reiff, M Gamir, G Higgins, I Koné-Paut, OY Jones, E Chalom, N Ilowite, C Wouters, MJ McIlraith, S Liu, H Kupper, EH Giannini, A Martini

Etanercept in juvenile idiopathic arthritis: Who will benefit?

  • Open Access
  • Oral presentation

MH Otten, FHM Prince, W Armbrust, R ten Cate, EPAH Hoppenreijs, M Twilt, Y Koopman-Keemink, SL Gorter, KM Dolman, JF Swart, JM van den Berg, NM Wulffraat, MAJ van Rossum, LWA van Suijlekom-Smit

Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis

  • Open Access
  • Oral presentation

EL Boulter, L Beard, C Ryder, CA Pilkington

Characterization of tonsil infiltration and gene expression profile of innate sensors in PFAPA patients

  • Open Access
  • Oral presentation

S Chiesa, MA Pelagatti, M Finetti, I Prigione, R Caorsi, D Lasiglié, R D’Agostino, A Sementa, A Omenetti, E Traggiai, A Martini, M Gattorno

Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy

  • Open Access
  • Oral presentation

Isabelle Jeru, Véronique Hentgen, Sylvain Normand, Philippe Duquesnoy, Emmanuelle Cochet, Adriana Delwail, Gilles Grateau, Sandrine Marlin, Serge Amselem, Jean-Claude Lecron

International cohort study for pediatric Behçet’s Disease: update 2011

  • Open Access
  • Oral presentation

I Koné-Paut, M Darce Bello, F Shahram, M Gattorno, R Cimaz, B Chkirate, K Bouayed, M Hofer, S Ozen, J Anton, I Tugal Tutkum, J Kümmerle-Deschner, S Benamour, S Assad Khalil, L Cantarini, A Faye, A Letierce, TA Tran, F Davatchi, O Kasapcopur, A Al Mayouf, C Pajot, S Nielsen, L Lepore, W Bono

Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients

  • Open Access
  • Oral presentation

W de Jager, SJ Vastert, BJ Noordman, D Holzinger, W Kuis, BJ Prakken, NM Wulffraat

Creation of a cohort of French patients with chronic recurrent multifocal osteitis : preliminary results

  • Open Access
  • Oral presentation

J Wipff, MA Dumitrescu, M Lorrot, S Kettani, A Faye, S Lacassagne, B Bader-Meunier, R Mouy, C Wouters, M Desjonquères, S Jean, V Despert, A Duquesne, I Lemelle, P Pillet, M Grall-Lerosey, P Quartier, C Job-Deslandre

The development of a new service for the management of Non-inflammatory Musculoskeletal Pain

  • Open Access
  • Oral presentation

S Bhagat, C Bernie, A Morgan, C Pilkington, SM Maillard

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial

  • Open Access
  • Oral presentation

PJ Hashkes, SJ Spalding, EH Giannini, B Huang, G Park, KS Barron, MH Weisman, N Pashinian, AO Reiff, J Samuels, D Wright, DL Kastner, DJ Lovell

A novel mutatioin in the PSTPIP1 gene is associated with an autoinflammatory disease distinct from classical PAPA syndrome

  • Open Access
  • Oral presentation

D Holzinger, J Austermann, P Lohse, I Aksentijevich, S Holland, M Gattorno, C Rodríguez-Gallego, S Fessatou, B Isidor, S Tokio, J Bernstein, B Sampson, C Sunderkoetter, J Roth

Toll-like receptor 2 polymorphism in juvenile dermatomyositis

  • Open Access
  • Oral presentation

P Mathiesen, C Enevold, T Lange, B Kornblit, S Nielsen, K Müller

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases

  • Open Access
  • Oral presentation

MW Heijstek, N Groot, M Scherpenisse, C Tacke, G Berbers, F van der Klis, NM Wulffraat

Predictors of disability in children with inflammatory arthritis, two and three years after first presentation to paediatric rheumatology. Results from the childhood arthritis prospective study (CAPS)

  • Open Access
  • Oral presentation

R Carrasco, J Cobb, E Baildam, H Foster, J Gardner-Medwin, A Chieng, L Wedderburn, J Davidson, K Hyrich, W Thomson

National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry

  • Open Access
  • Poster presentation

C Bibalo, G Paloni, L Lepore, M Gattorno, M Finetti, F Zulian, G Martini, M Alessio, M Cattalin, A Stabile, D Rigante, A Insalaco, R Manna, R Gallizzi, L Obici, L Cantarini, S Martino, R Cionsolini

Amyloidosis in a child with Hyperimmunoglobulin D syndrome

  • Open Access
  • Poster presentation

Ruhan Dusunsel, Zubeyde Gunduz, Funda Bastug, Ismail Dursun, Hakan M Poyrazoglu, Sibel Yel, Sebahat Tulpar, Kemal Deniz, Erkan Demirkaya

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra

  • Open Access
  • Poster presentation

MS Camacho Lovillo, E Iglesias, O Neth, V Santa-María, JL Gavilán

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)

  • Open Access
  • Poster presentation

MS Camacho Lovillo, E Iglesias, O Neth, V Santa-María, A Sánchez, J Bernabeu

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab

  • Open Access
  • Poster presentation

C Galeotti, A Boucheron, S Guillaume, I Koné-Paut

Interleukin-1 antagonists in Mevalonate Kinase Deficiency

  • Open Access
  • Poster presentation

C Galeotti, L Rossi-Semerano, S Guillaume, A Duquesne, P Pillet, O Richer, E Hachulla, I Koné-Paut

A case of early onset renal sarcoidosis complecated with multiple enchondromatosis

  • Open Access
  • Poster presentation

U Kaneko, S Toyabe, M Uchiyama

A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report

  • Open Access
  • Poster presentation

Sandra Hansmann, Christiane Zimmer, Monika Moll, Nikolaus Rieber, Jasmin B Kuemmerle-Deschner

A case of autoimmune lymphoproliferative syndrome in a 3 years-old patient

  • Open Access
  • Poster presentation

IN Lavrentieva, SR Rodionovskaya, IN Tsymbal, MA Maschan, TA Visotskaya

Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia

  • Open Access
  • Poster presentation

Onur Akin, Erkan Demirkaya, Adem Polat, Ezgi Deniz Batu, Yusuf Tunca, Cengizhan Acikel, Harun Peru, Betul Sozeri, Ismail Dursun, Hakan Poyrazoglu, Faysal Gok, Seza Ozen

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

  • Open Access
  • Poster presentation

B Bader-Meunier, P Hachulla, J Kuemmerle-Deschner, M Gattorno, N Patel, R Preiss, K Lheritier, T Imagawa, R Nishikomori, H Takada, T Heike, T Hara, S Yokota

Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs

  • Open Access
  • Poster presentation

Ulrich Meinzer, Isabelle Marie, Isabelle Koné-Paut, Tu-Anh Tran

Therapy of autoinflammatory diseases: a review of the literature

  • Open Access
  • Poster presentation

NM ter Haar, J Frenkel

β-Confident-registry: aiming to be largest-ever studied cohort of cryopyrin-associated periodic syndromes (CAPS) patients. Study design and baseline characteristics

  • Open Access
  • Poster presentation

J Kuemmerle-Deschner, D Rothenbacher, U Walker, H Tilson, H Hoffman, P Hawkins

FMF in heterozygotes: are we able to accurately diagnose the disease in very young children?

  • Open Access
  • Poster presentation

Véronique Hentgen, Katia Stankovic Stojanovic, Gilles Grateau, Serge Amselem, Isabelle Jeru

Therapy of autoinflammatory diseases: results from an international registry

  • Open Access
  • Poster presentation

NM ter Haar, J Frenkel, P Woo, L Cantarini, H Lachmann, A Insalaco, M Hofer, Y Uziel, S Ozen, S Nielsen, A Naselli, C Modesto, SM Al-Mayouf, I Kone-Paut, I Nikishina, N Iagaru, L Obici, E Papadopoulou-Alataki, D Rigante, C Boros, A Martini, N Ruperto, M Gattorno

Behçet disease: evaluation of clinical manifestations in Turkish children

  • Open Access
  • Poster presentation

Erkan Demirkaya, Celal Saglam, Turker Turker, Sevcan Bakkaloglu, Balahan B Makay, Bora Gulhan, Banu Acar, Nuray A Ayaz, İsmail Dursun, Adem Polat, Cetin Kocabiyik, Faysal Gok, Erbil Unsal, Ozgur Kasapcapur, Seza Özen

Survey of off-label anti-IL1 treatments in France: preliminary data

  • Open Access
  • Poster presentation

L Rossi-Semerano, B Fautrel, C Galeotti, I Koné-Paut

Hyper-IgD syndrome: a new mutation (p.R277G) with a severe phenotype

  • Open Access
  • Poster presentation

J Santos, JI Arostégui, MJ Brito, C Neves, M Conde

Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

  • Open Access
  • Poster presentation

R Caorsi, L Lepore, F Zulian, M Alessio, A Stabile, M Finetti, A Martini, M Gattorno

Chronic nonbacterial osteomyelitis in children

  • Open Access
  • Poster presentation

A Desdoits, S Gandon-Laloum

Impact of mevalonate kinase deficiency (MKD) on the quality of life in children and young adults: a national multicentre study

  • Open Access
  • Poster presentation

Silvia Federici, Alberto Tomasini, Antonella Meini, Matteo Doglio, G Calcagno, Francesco Zulian, Rita Consolini, Martina Finetti, Luciana Breda, Roberta Caorsi, Laura Obici, Romina Gallizzi, Donato Rigante, Mariolina Alessio, Alberto Martini, Marco Gattorno

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes

  • Open Access
  • Poster presentation

F Zulian, G Vigo, F Vittadello, I Ceccherini, L Obici, G Martini

Tonsillectomy efficacy is comparable to the standard medical treatment in PFAPA syndrome

  • Open Access
  • Poster presentation

G Vigo, G Martini, S Zoppi, F Vittadello, F Zulian

Mc Cune Albright syndrome: estimation of bone strength parameters and response to treatment using peripheral Quantitive Computed Tomography (pQCT) of the tibia

  • Open Access
  • Poster presentation

E Atsali, KD Stathopoulos, E Stefos, H Bournazos, G Kiniklis, A Papadimitriou, P Nicolaidou, AB Zoubos, G Skarantavos

Phalangeal microgeodic syndrome, a case series

  • Open Access
  • Poster presentation

J Toelen, T Van Ackere, S Brijs, A Brijs, A Eykens, P Maroteaux, C Wouters

Diagnostic difficulties in patients with attenuated form of MPS VI

  • Open Access
  • Poster presentation

V Opoka – Winiarska, A Jurecka, A Tylki – Szymańska, A Emeryk

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children

  • Open Access
  • Poster presentation

Assunta CH Ho, Joannie Hui, KH Chan, KL Liu, Bobby KW Ng, Ivan FM Lo, STS Lam

FOP in South Africa: awareness leads to diagnosis

  • Open Access
  • Poster presentation

Christiaan Scott

Unifocal and multifocal chronic non-bacterial osteomyelitis (CNO) in children

  • Open Access
  • Poster presentation

G Zanon, A Insalaco, G Martini, S Corradin, P Zucchetta, L Tanturri, M Garganese, F De Benedetti, F Zulian

Description Kelley-Seegmiller syndrome (partial HPRT deficiency manifesting as a gout-urolithiasis syndrome) in a patient of 15 years old

  • Open Access
  • Poster presentation

SR Rodionovskaya, NZ Zokirov, ES Fedorov, IN Tsymbal, SO Salugina, MS Eliseev

Type 1 diabetes associated with Hashimoto’s thyroiditis and juvenile rheumatoid arthritis : a case report

  • Open Access
  • Poster presentation

Antonio Mellos, Angela Mauro, Milena Di Meglio, Carmela Granato, Laura Perrone, Alma N Olivieri

An atypical presentation of pyoderma gangrenosum with systemic features and pulmonary involvement in a toddler

  • Open Access
  • Poster presentation

Despoina Maritsi, Christina Neila, Millie Konstantinidou, Elizabeth Dimitriou

Aortoarteritis and cardiomyopathy in a child with Blau Syndrome

  • Open Access
  • Poster presentation

RP Khubchandani, RP Hasija, I Touitou, C Khemani

Experience with pediatric sarcoidosis at a centre in Mumbai, India

  • Open Access
  • Poster presentation

RP Khubchandani, RP Hasija, I Touitou, C Khemani

Pediatric sarcoidosis: report of seven cases

  • Open Access
  • Poster presentation

Yépez Ricardo, Malagon Clara, Olmos Carlos

Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies

  • Open Access
  • Poster presentation

D Moshous, I Meyts, S Fraitag, C Janssen, M Debré, F Suarez, J Toelen, K De Boeck, T Roskams, A Deschildre, C Picard, C Bodemer, C Wouters, A Fischer

Quality of life in patients with juvenile arthritis: adalimumab might make a difference

  • Open Access
  • Poster presentation

Rina Denisova, Ekaterina Alexeeva, Saniya Valieva, Tatyana Bzarova, Elena Mitenko, Tatyana Sleptsova, Kseniya Isayeva

Ultrasonography and colour Doppler in juvenile idiopathic arthritis: Diagnosis and follow-up of ultrasound-guided steroid injection in the wrist

  • Open Access
  • Poster presentation

Louise Laurell, Michel Court-Payen, Susan Nielsen, Marek Zak, Anders Fasth

Musculo-skeletal Ultrasound in paediatric rheumatology: experience of one University Hospital

  • Open Access
  • Poster presentation

J Madruga Dias, M Manuela Costa, F Saraiva, JA Pereira da Silva

Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study

  • Open Access
  • Poster presentation

Maria Teresa Terreri, Vanessa Bugni, Carolina Tavares, Sônia Mitraud, Rita NV Furtado, Jamil Natour, Maria Odete Hilário

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography

  • Open Access
  • Poster presentation

D Pradsgaard, A Spannow, C Heuck, A Hørlyck, T Herlin

Recurrent swelling of right knee: a case of hemangioma

  • Open Access
  • Poster presentation

J Wipff, H Guerini, C Deslandre

Sacroilitis on magnetic resonance imaging in children presenting with low backache: interobserver reliability between radiologists

  • Open Access
  • Poster presentation

Athimalaipet Ramanan, Shabina Habibi, M Thyagarajan, M Bradley

Musculoskeletal ultrasound (MSK-US) in pediatric rheumatology: European preliminary results of the survey of the Pediatric Ultrasound Group of the Omeract Ultrasound Task Force

  • Open Access
  • Poster presentation

Silvia Magni-Manzoni, Johannes Roth, Paz Collado, Esperanza Naredo, Maria Antonietta D'Agostino, Pietro Merli, Valentina Muratore, Sandrine Jousse-Joulin

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?

  • Open Access
  • Poster presentation

C Malattia, A Consolaro, S Pederzoli, MB Damasio, R Hasija, M Mazzoni, A Madeo, A Beltramo, S Viola, A Buoncompagni, C Mattiuz, A Ravelli, A Martini

Thrombotic microangiopathy in juvenile dermatomyositis

  • Open Access
  • Poster presentation

A Frolenko, N Bervina, M Kagan

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients

  • Open Access
  • Poster presentation

E Iglesias, J Antón, S Ricart, J Ros, V Torrente, R Bou, MA González, A Vicente

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)

  • Open Access
  • Poster presentation

Liza J McCann, Clarissa Pilkington, Laura Beard, Angelo Ravelli, Adam Huber, Lucy R Wedderburn

Juvenile dermatomyositis in Western Switzerland

  • Open Access
  • Poster presentation

F Bellutti Enders, M Hofer

Disease patterns in juvenile dermatomyositis patients from Mumbai, India

  • Open Access
  • Poster presentation

RP Khubchandani, D Mankad, PR Chickermane

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis

  • Open Access
  • Poster presentation

Violetta Opoka – Winiarska, Renata Jawniak, Andrzej Emeryk

Calcinosis as a complication of juvenile dermatomyositis (JDM)

  • Open Access
  • Poster presentation

Malagón Clara, Yépez Ricardo, Contreras Luz

Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma

  • Open Access
  • Poster presentation

BERG Bica, CT França, AB Vargas

Dyslipidemia in active juvenile dermatomyositis patients

  • Open Access
  • Poster presentation

KT Kozu, CA Silva, EF Borba, AME Sallum, VST Viana, LMA Campos

Inflammatory myositis in the pediatric rheumatology clinical practice – a case series

  • Open Access
  • Poster presentation

S Melo Gomes, M Conde, MP Ramos, JA Melo Gomes

Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report

  • Open Access
  • Poster presentation

Selmanovic-Mulaosmanovic Velma, Dizdarevic-Omercahic Aida, Mornjakovic-Franca Amela, Cengic Adisa

Development and initial validation of a new functional ability tool for juvenile dermatomyositis

  • Open Access
  • Poster presentation

GC Varnier, A Consolaro, C Malattia, AP Rao, A Madeo, E Demirkaya, D Lazarevic, A Civino, A Martini, A Ravelli

Juvenile dermatomyositis (JDM) sine myositis

  • Open Access
  • Poster presentation

C Schuetz, V Mohr, C Pfeiffer, A Schulz, KM Debatin

CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis

  • Open Access
  • Poster presentation

Yvonne Vercoulen, Elisabeth F Elst, Jenny Meerding, Maud Plantinga, Hemlata Varsani, Christa van Schieveen, Mette H Bakker, Mark Klein, Wim Spliet, R de Weger, Lucy Wedderburn, Annet van Royen- Kerkhof, Berent J Prakken

Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre

  • Open Access
  • Poster presentation

Raquel Campanilho-Marques, Ana Filipa Mourão, Sónia Melo Gomes, João Eurico Fonseca, Helena Canhão, Carla Macieira, Filipa Ramos, JA Pereira da Silva

Mesenchymal stem cells and JIA

  • Open Access
  • Poster presentation

JF Swart, S de Roock, F Hofhuis, W Kuis, BJ Prakken, AC Martens, I Slaper-Cortenbach, NM Wulffraat

Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Arina Lazareva, Valda Stanevicha, Jelizaveta Semjonova, Ruta Shantere, Inita Buliņa

Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease

  • Open Access
  • Poster presentation

TA Tran, JC Lecron, D Pariente, I Jéru, A Delwail, I Kone-Paut, U Meinzer

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

  • Open Access
  • Poster presentation

G Espada, SM Meiorin, L Guerini, M Alvarez, Giupponi

B cells depletion as a value alternative therapeutic in pediatric autoimmune disorders: 3 case reports

  • Open Access
  • Poster presentation

Joana Extreia, Inês Marques, Paula Afonso, Joaquim Rodrigues, Nuno Fernandes, Vera Silva

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”

  • Open Access
  • Poster presentation

I Marvillet, I Calvo Penadés, B López Montesinos, A Marco Puche

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy

  • Open Access
  • Poster presentation

G Espada, J Giupponi, C Cerqueiro

Preliminary results for 6 minute walk values in healthy German children

  • Open Access
  • Poster presentation

Ivan Foeldvari, Günther W Himmelmann

Juvenile localized scleroderma: review of 44 patients

  • Open Access
  • Poster presentation

E Iglesias, J Antón, S Ricart, J Ros, V Torrente, R Bou, MA González, A Vicente

Decreased digital skin microvascular blood flow before and after cold stimulus using Laser Doppler imaging in juvenile systemic sclerosis

  • Open Access
  • Poster presentation

Maria Teresa RATerreri, Daniela Gerent Petry Piotto, Marcelo José Uchôa Corrêa, Cristiane Kayser, Claudio Len

Autologous stem cell transplantation in two children with disabling pansclerotic morphea

  • Open Access
  • Poster presentation

M Moll, U Holzer, C Zimmer, N Rieber, JB Kuemmerle-Deschner

Childhood morphea does not impair self-perception

  • Open Access
  • Poster presentation

R Carlomagno, G Russo, C Forni, F Orlando, R Vitale, N Scotti, M Alessio

Cutaneous PAN and Common Variable Immunodeficiency: what causes what?

  • Open Access
  • Poster presentation

Ilaria Pagnini, Gabriele Simonini, Francesca Lippi, Chiara Azzari, Rolando Cimaz

Kawasaki disease in a northern region of Italy

  • Open Access
  • Poster presentation

Elena Corinaldesi, MFabi, G Savorelli

Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases

  • Open Access
  • Poster presentation

YO Kostina, GA Lyskina, GM Rabieva, EV Uspenskaya

Increased serum Interleukin-18 in the active phase of Henoch-Schönlein purpura

  • Open Access
  • Poster presentation

Donato Rigante, Anna Zampetti, Giulia Bersani, Beatrice Bartolomei, Claudio Feliciani, Achille Stabile

Role of CD4+CD25hiCD127lo/-FoxP3+ regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children

  • Open Access
  • Poster presentation

TA Tran, S Monteil, A Letierce, B Terrier, G Geri, D Saadoun, I Kone-Paut, B Salomon, M Rosenzwajg

Moyamoya disease. An important differential diagnosis to cerebral vasculitis

  • Open Access
  • Poster presentation

A Estmann, P Toftedal, AJ Schou

Coronary artery abnormalities in Kawasaki disease according to patient age

  • Open Access
  • Poster presentation

Esmeralda Nuñez, Patricia Martínez, Victorio Cuenca, Francisco Jesus García, David Moreno, Antonio Urda

An 11-year-old boy with long lasting headaches

  • Open Access
  • Poster presentation

Olga Vougiouka, Venetia-Maria Vraila, Lydia Kossiva, Dimitra Kallinikou, Dimitrios Kafetzis

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children

  • Open Access
  • Poster presentation

AS Sacri, B Ranchin, B Florkin, H See, T Ulinski, H Flodrops, S Decramer, R Salomon, P Quartier, J Harambat

Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study

  • Open Access
  • Poster presentation

Maria Teresa Terreri, Gleice Clemente, Sheila K Oliveira, Marise Lessa, Clóvis Artur Silva, Adriana Sallum, Lúcia Campos, Flávio Sztajnbok, Rosana Gasparello, André Cavalcanti, Virginia Ferriani, Teresa Robazzi, Silvana Sacchetti, Maria Odete Hilário

Cutaneous polyarteriitis nodosa with Grave’s disease and cholestatic liver disease

  • Open Access
  • Poster presentation

V Vassileva, B Varbanova

Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years

  • Open Access
  • Poster presentation

Masa Vikic Topic, Ivan Malcic, Danica Batinic, Danko Milosevic, Mandica Vidovic, Katarina Starcevic, Kristina Potocki, Branko Malenica, Marija Jelusic-Drazic

Disease activity in paediatric vasculitis: development of a generic assessment tool - PVAS

  • Open Access
  • Poster presentation

P Dolezalova, PA Brogan, S Özen, S Benseler, J Anton, J Brunner, DA Cabral, R Cimaz, KM O´Neil, C Wallace, N Wilkinson, R Luqmani

Primary systemic vasculitis in children in Estonia: a retrospective study from 2001-2010

  • Open Access
  • Poster presentation

Sirje Tarraste, Mari Laan, Jaanika Illison, Chris Pruunsild

Primary angiitis of the central nervous system in children - case series

  • Open Access
  • Poster presentation

V Krakovská, R Stibitzová, T Pískovský, Z Vrábelová, M Macků, D Němcová, P Doležalová

ANCA-associated vasculitides in childhood

  • Open Access
  • Poster presentation

Diána Garan, Zsófia Bence, Zsófia Gács, András Szabó, Tamás Constantin

Unusual presentations of Churg Strauss syndrome in paediatrics: a tale of 2 masses from one centre experience

  • Open Access
  • Poster presentation

E Baildam, C Pain, F McErlane, G Cleary, M Beresford, L McCann

Outcome of children with panarteritis nodosa: a series of 30 cases

  • Open Access
  • Poster presentation

E Merlin, R Mouy, P Quartier

Recurrent refractory Kawasaki disease

  • Open Access
  • Poster presentation

P Costa Reis, S Nativ, A Starr, L Imundo, A Eichenfield

Unusual organ involvment in Henoch–Schönlein purpura patients; a roprt from Iran

  • Open Access
  • Poster presentation

Vahid Ziaee, Mohamad-Hassan Moradinejad

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis

  • Open Access
  • Poster presentation

LA Katargina, EV Denisova, AV Starikova, NV Lubimova, IP Nikishina

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Sergio Davì, Bianca Lattanzi, Silvia Rosina, Erkan Demirkaya, Nicolino Ruperto, Alberto Martini, Randy Q Cron, Angelo Ravelli

Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism

  • Open Access
  • Poster presentation

G Minnone, R Strippoli, G Prencipe, L De Pasquale, C Bracaglia, A Insalaco, F De Benedetti, L Bracci-Laudiero

Genetic susceptibility to juvenile idiopathic arthritis in Iranian children

  • Open Access
  • Poster presentation

Reza Shiari, Shirin Farivar, Elham Hadia

A novel therapeutic approach for macrophage actıvatıon syndrome due to SoJIA

  • Open Access
  • Poster presentation

Nuray Aktay Ayaz, Esra Şevketoğlu, Sait Serdar Oral, Tuğba Kontbay, Deniz Aybar, Sami Hatipoğlu, Gönül Aydoğan

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

EH Pieter Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia MF Pluijm, Robert de Jonge

Down regulation of anti-inflammatory cytokines in ileal mucosa associates with active disease in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Miika Arvonen, Paula Vähäsalo, Sami Turunen, Harri Salo, Outi Vaarala, Tuomo J Karttunen

Serum tumor necrosis factor alpha increased during remission with Etanercept

  • Open Access
  • Poster presentation

Mihaela Spirchez, Gabriel Samasca, Claudia Bolba, Nicolae Miu

Interleukin-6 overproduction correlates with disease activity and severity in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Mihaela Spirchez, Gabriel Samasca, Claudia Bolba, Nicolae Miu

Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment

  • Open Access
  • Poster presentation

C Modesto, F Caracsegui, S Melendo, A Sanchez-Montanez, Manel Roig

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Rolando Cimaz, Lorenzo Cosmi, Laura Maggi, Gabriele Simonini, Teresa Giani, Ilaria Pagnini, Veronica Santarlasci, Manuela Capone, Valentina Querci, Francesco Liotta, Enrico Maggi, Francesco Annunziato

Early treatment with infliximabin patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

TV Sleptsova, EI Alexeeva, SI Valieva, TM Bzarova, KB Isayeva, RV Denisova, EV Mitenko

MRI evaluation of clinical remission in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M van Veenendaal, R Hemke, MI Bos, M Maas, MAJ van Rossum, TW Kuijpers

A biopsychosocial approach to parents of children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Z Georgiadou, M Trachana, P Pratsidou-Gertsi, G Pardalos, M Stavrakidou, I Karagiannaki

Think about the joints

  • Open Access
  • Poster presentation

ET Mosley, AM McMahon

The role of clinical pilates exercises in children wıth juvenile idiopathic arthritis: a pilot study

  • Open Access
  • Poster presentation

Edibe Unal, Pinar Dizmek, Yelda Bilginer, Asli Celebi Tayfur, Nesrin Besbas, Seza Ozen

The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

SA Alfantaki, S Stavrou, A Siamopoulou-Mavridou

Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Yelda Bilginer, Eda Utine, Özgür Kasapçopur, Bora Gülhan, Erkan Demirkaya, Rezan Topaloğlu, Ali Düzova, Fatih Özaltın, Mehmet Alikaşifoğlu, Seza Özen

Radiological cervical spine involvement in polyarticular idiopathic juvenile arthritis

  • Open Access
  • Poster presentation

J Wipff, M Elhai, R Bazeli, A Feydy, A Kahan, C Job-Deslandre

Paediatric rheumatology services through the parents’ eyes: a pilot study to develop a disease specific questionnaire to monitor deficiencies of care

  • Open Access
  • Poster presentation

A Thon, C Mokroß, F Dressler, K Stahl, W Günther, G Ullrich, G Steinkamp

Impact of a 2-yr anti-TNF treatment on the quality of life in JIA patients: a parent's/patient’s view

  • Open Access
  • Poster presentation

K Diafa, P Pratsidou-Gertsi, M Trachana, G Pardalos, F Kanakoudi-Tsakalidou

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)

  • Open Access
  • Poster presentation

M Nørgaard, T Herlin

Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Peter Stoustrup, Carlaberta Verna, Kasper D Kristensen, Annelise Küseler, Troels Herlin, Thomas K Pedersen

The effectiviness of an innovative web-based application to monitor HRQOL problems in paediatric rheumatology clinical practice

  • Open Access
  • Poster presentation

L Haverman, MAJ van Rossum, HSA Heymans, TW Kuijpers, MA Grootenhuis

Daily sleep quality and mood as predictors of pain in children with juvenile polyarticular arthritis

  • Open Access
  • Poster presentation

MH Bromberg, KM Gil, LE Schanberg

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Takako Miyamae, Tomo Nozawa, Masako Kikuchi, Toshitaka Kizawa, Tomoyuki Imagawa, Shumpei Yokota

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Maja Bulatović, Sebastiaan Vastert, Frederik Verweij, Nico Wulffraat, Femke van Wijk, Berent Prakken

Autoimmune response following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Nadia E Aikawa, Claudia Goldenstein-Schainberg, M Vendramini, Lucia MA Campos, Carla G Saad, Julio B Moraes, Alberto Duarte, Alex R Precioso, Maria CST Timenetsky, E Bonfá, Clovis A Silva

Osteonecrosis of the femoral heads in patients with systemic onset juvenile idiopathic arthritis: comparison of the results of radiological and morphological methods

  • Open Access
  • Poster presentation

D Alexeev, I Nikishina, A Smirnov, L Semenova, L Bogjeva, S Makarov, S Radenska-Lopovok, D Ivanov

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

O Nemiche, R Dagner, P Quartier, R Cimaz, O Richer, P Pillet, M Hofer

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa

  • Open Access
  • Poster presentation

Kate Weakley, Monika Esser, Chris Ranier Pope, Christiaan Scott

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA

  • Open Access
  • Poster presentation

G Deslypere, C Wouters, J Joly, R Westhovens

Impact of biologics on growth in children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

F Uettwiller, G Pinto, M Polak, P Quartier

Turkish version of the pediatric quality of life inventory (PedsQL) 3.0 arthritis module: a reliability and validity study

  • Open Access
  • Poster presentation

Tarakci Ela, Baydogan Nilay, Kasapcopur Ozgur, Dirican Ahmet

QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Bulent Koca, Ozgur Kasapcopur, Suleyman Bakari, Emre Celik, Ozden Calay

P wave dispersion and cardiac involvement in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Bulent Koca, Ozgur Kasapcopur, Suleyman Bakari, Emre Celik, Ayse Guler Eroglu, Levent Saltik, Funda Oztunc, Ozden Calay

Arthralgia in children: the epidemiological study

  • Open Access
  • Poster presentation

VA Malievskiy

Systemic juvenile idiopathic arthritis in the republic of Bashkortostan

  • Open Access
  • Poster presentation

VA Malievskiy

Maximal inter-incisal distance in healthy school children in Switzerland

  • Open Access
  • Poster presentation

H van Waes, C Langerweger, L Mueller, CJ Kellenberger, RK Saurenmann

Sleep disorders in patients with juvenile idiopathic arthritis as assessed by the sleep disturbance scale for children

  • Open Access
  • Poster presentation

RP Khubchandani, AA Bagde, A Pistorio, RP Hasija

The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M Trachana, P Triantafyllou, A Vraka, E Kaitalidou, P Pratsidou-Gertsi

Determing an “autoimmune” phenotype in systemic JIA

  • Open Access
  • Poster presentation

N Fischer, B Huegle, JP Haas

Enthesitis related arthritis- 2 distinct clinical phenotypes?

  • Open Access
  • Poster presentation

Corinne Fisher, John Ioannou, Debajit Sen

A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents

  • Open Access
  • Poster presentation

Seza Ozen, Yesim Aydin Son, Yener Tuncel, Erkan Demirkaya, Yelda Bilginer, Cengizhan Acikel, Bilge Volkan Salancı, Ozgur Kasapcopur, Erbil Unsal, Nesrin Besbas, Mehmet Alikasifoglu

2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?

  • Open Access
  • Poster presentation

Janneke Anink, Koert M Dolman, Merlijn J van den Berg, Mira van Veenendaal, Taco W Kuijpers, Marion AJ van Rossum

Validation of the juvenile artritis disease activity score in 1124 patient visits

  • Open Access
  • Poster presentation

LD de Vries, MW Heijstek, N Groot, M Bulatović, NM Wulffaat

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting

  • Open Access
  • Poster presentation

EB Nordal, M Zak, L Berntson, K Aalto, P Lahdenne, S Peltoniemi, S Nielsen, T Herlin, B Straume, A Fasth, M Rygg

Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?

  • Open Access
  • Poster presentation

Adem Polat, Erkan Demirkaya, Turker Turker, Yelda Bilginer, Erbil Unsal, Muferet Erguven, Hakan Poyrazoglu, Ozgur Kasapcopur, Faysal Gok, Seza Ozen

Pain and impact of pain on function in JIA-patients aged 10-19 years

  • Open Access
  • Poster presentation

M Lanzinger

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra

  • Open Access
  • Poster presentation

Marco Gattorno, Aldo Naselli, Andrea Accogli, Sabrina Chiesa, Roberta Caorsi, Jessica Tebaldi, Antonella Buoncompagni, Nicola Ruperto, Stefania Viola, Paolo Picco, Angelo Ravelli, Alberto Martini

Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients

  • Open Access
  • Poster presentation

Falcini Fernanda, Stagi Stefano, Cavalli Loredana, Masi Laura, Capannini Serena, Ceri Lorenzo, Matucci Cerinic Marco, Brandi Maria Luisa

Does childhood health assessment questionnaire can predict outcome of patients with juvenile idiopathic arthritis?

  • Open Access
  • Poster presentation

G Susic, R Stojanovic, I Soldatovic, N Damjanov, G Radunovic

Relationship of serum ghrelin, leptin, resistin, adiponectin levels with nutritional status and inflammatory determinants in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Sanem Eren, Oya Sayın, Balahan Makay, Tuncay Küme, Erbil Ünsal, Filiz Kuralay, Nur Arslan

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)

  • Open Access
  • Poster presentation

A Remesal, S Murias, MI Gonzalez, I Tarjuelo, R Merino

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)

  • Open Access
  • Poster presentation

S Murias, A Remesal, L Latorre, M Gomez, R Merino

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

  • Open Access
  • Poster presentation

F De Benedetti, H Brunner, N Ruperto, R Schneider, P Woo, R Burgos-Vargas, P Dolezalova, R Joos, N Wulffraat, Z Zuber, F Zulian, R Allen, D Brown, J Chaitow, M Pardeo, G Espada, B Flato, V Gerloni, G Horneff, S Wright, A Kenwright, D Lovell, A Martini

Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment

  • Open Access
  • Poster presentation

OU Konopelko, ES Zholobova, OS Rozvadovskaya

Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA

  • Open Access
  • Poster presentation

J Vojinovic, A Furlan, N Damjanov, C D’Urzo, CA Dinarello

Early onset chronic arthritis associated with chromosome deletion 22 q11.2 syndrome. Is it juvenile idiophatic arthritis?

  • Open Access
  • Poster presentation

Esmeralda Nuñez, Pablo De Cabo, Gisela Diaz, Rocio Galindo, Antonio Urda

Coeliac disease and intestinal inflammation in juvenil idiopathic arthritis

  • Open Access
  • Poster presentation

Esmeralda Nuñez, Rocio Galindo, Enrique Lopez, Gisela Diaz, Maria Isabel Vicioso, Carlos Sierra

Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis

  • Open Access
  • Poster presentation

De Sanctis Sara, Breda Luciana, Del Torto Marianna, Nozzi Manuela, Lucantoni Marta, Sebastiani Marianna, Mohn Angelika, Chiarelli Francesco

Preliminary data on insulin sensitivity in non-obese prepubertal children affected by juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Breda Luciana, Gaspari Stefania, De Sanctis Sara, Draghessi Antonella, Savino Alessandra, Scardapane Alessandra, Mohn Angelika, Chiarelli Francesco

DNase I levels and disease outcome in JIA patients treated with etanercept

  • Open Access
  • Poster presentation

D Lazarević, J Vojinović, G Sušić, N Damjanov, J Bašić

Mandibular ramus length and condylar changes in Juvenile Idiopathic Arthritis

  • Open Access
  • Poster presentation

P Arvonen, J Naujokaityte, M Arvonen, ML Perkiömäki, P Vähäsalo, P Pirttiniemi

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients

  • Open Access
  • Poster presentation

L De Somer, K Lambot, C Wouters, B Bader-Meunier

Temporomandibular joint involvement (TMJ), a silent disease with severe alterations in young adulthood patients affected by juvenile idiophatic arthritis (JIA)

  • Open Access
  • Poster presentation

Falcini Fernanda, Melchiorre Daniela, Ceri Lorenzo, Capannini Serena, Denaro Valentina, Biondi Katia, Bosco Mario, Matucci Cerinic Marco

Juvenile idiopathic arthritis and Wegener granulomatosis: causal or casual relationship?

  • Open Access
  • Poster presentation

Balahan Makay, Tuba Tuncel, Nevin Uzuner, Erbil Ünsal

One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)

  • Open Access
  • Poster presentation

V Torrente-Segarra, P Santín, L Casas, S Ricart, R Bou, JB Ros, N Rodríguez, J Antón López

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients

  • Open Access
  • Poster presentation

I Melki, J Djadi-Prat, AM Prieur, C Job-Deslandre, P Quartier, C Elie, B Bader Meunier

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

  • Open Access
  • Poster presentation

O Vougiouka, E Atsali, C Panousi-Vlahou, S Azaris, A Koidou

German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA)

  • Open Access
  • Poster presentation

G Dueckers, N Guellac, M Arbogast, G Dannecker, I Foeldvari, M Frosch, G Ganser, A Heiligenhaus, G Horneff, A Illhardt, I Kopp, R Krauspe, B Markus, H Michels, M Schneider, W Singendonk, H Sitter, M Spamer, N Wagner, T Niehues

An Altered Peptide Ligand derived from heat-shock protein 60 induces regulatory T cells in JIA patients and suppresses adjuvant-induced arthritis

  • Open Access
  • Poster presentation

Dolores Cantera, Noraylis Lorenzo, Ariana Barberá, Amarys Alonso, Yamile Heredia, Elsy Chall, Lourdes Franco, Ramón G Padrón, Maria C Domínguez

Autologous stem cell transplantation in autoimmune arthritis restores immune homeostasis by renewal of the natural Treg compartment

  • Open Access
  • Poster presentation

T van den Broek, E Delemarre, J Meerding, E Wehrens, F Broere, N Wulffraat, M Boes, B Prakken, F van Wijk

Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)

  • Open Access
  • Poster presentation

PCE Hissink Muller, I Brederije, DMC Brinkman DMC, CF Allaart, LWA van Suijlekom-Smit, MAJ van Rossum, R ten Cate

MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis

  • Open Access
  • Poster presentation

Christiaan Scott, Asgar Kalla

Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report

  • Open Access
  • Poster presentation

MG Alpigiani, P Salvati, M Muraca, S Callegari, G Tripodi, R Lorini, MB Michelis, S Boero

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up

  • Open Access
  • Poster presentation

MG Alpigiani, P Salvati, S Callegari, A Bagnis, M Papadia, CE Traverso, R Lorini

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment

  • Open Access
  • Poster presentation

S Ricart, J Calzada, V Torrente, R Bou, J Anton

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials

  • Open Access
  • Poster presentation

E Demirkaya, N Ruperto, R Galasso, A Ravelli, E Palmisani, A Martini, A Pistorio

JIA affected sibling pairs present high correlation for ANA and ILAR category

  • Open Access
  • Poster presentation

G Filocamo, C Malattia, I Foeldvari, V Stanevicha, S Nielsen, T Herlin, C Pruunsild, F Zulian, Z Balogh, F Dressler, I Rumba, MG Alpigiani, E Cortis, F Falcini, R Trauzeddel, G Calcagno, L Lepore, M Alessio, DN Glass, SD Thompson, A Martini, N Ruperto

The PRINTO provisional definition of remission in juvenile dermatomyositis

  • Open Access
  • Poster presentation

D Lazarevic, A Pistorio, P Miettunen, A Ravelli, C Malattia, C Pilkington, N Wulffraat, S Garay, M Hofer, P Quartier, P Dolezalova, I Calvo Penades, V Ferriani, G Ganser, O Kasapcopur, JA Melo-Gomes, M Wierzbowska, A Martini, N Ruperto

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?

  • Open Access
  • Poster presentation

A Officioso, G Griso, C Storace, A Battagliese, R Carlomagno, M Alessio

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

A Consolaro, G Filocamo, M Bertamino, E Palmisani, G Bracciolini, C Suffia, V Muratore, N Ruperto, A Martini, A Ravelli

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

B Schiappapietra, A Consolaro, S Magni-Manzoni, N Solari, S Lanni, S Davì, S Pederzoli, G Bracciolini, A Martini, A Ravelli

Assessment of active TGFβ with a bioassay

  • Open Access
  • Poster presentation

Annemieke Laarhoven, Katja Heitink, Wilco de Jager, Berent Prakken, Femke van Wijk

Auto-antibody testing for children on biologic therapies for rheumatological conditions: results of audit

  • Open Access
  • Poster presentation

Julie Duncan, Jill Heath, Eileen Baildam, Gavin Cleary, Michael Beresford, Liza J McCann

Intra-articular corticosteroid therapy in oligoarticular juvenile arthritis: our clinical experience

  • Open Access
  • Poster presentation

C Trigilia, T Timpanaro, G Caff, G Belfiore, V Pavone, P Barone, R Garozzo

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab

  • Open Access
  • Poster presentation

G Horneff, S Fitter, HI Huppertz, I Foeldvari, K Kuemmerle-Deschner, R Kuester, N Tzaribacev, A Thon, M Borte, G Ganser, R Trauzeddel, K Minden

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

E Alexeeva, R Denisova, S Valieva, T Bzarova, K Isayeva, T Sleptsova, E Mitenko

Adverse events of methotrexate treatment in JIA

  • Open Access
  • Poster presentation

J in ‘t Veld, NM Wulffraat, JF Swart

The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma

  • Open Access
  • Poster presentation

Ristic Goran, Djokic Dragutin, Pasic Srdjan

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy

  • Open Access
  • Poster presentation

Ryoki Hara, Tomoyuki Imagawa, Takuma Hara, Masako Kikuchi, Takako Miyamae, Masaaki Mori, Shumpei Yokota

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)

  • Open Access
  • Poster presentation

JO Sato, TAP Fernandes, CB Nascimento, RG Brito, C Saad-Magalhães

Does standard phisiotherapy influence the health-related quality of life of JIA patients?

  • Open Access
  • Poster presentation

TMS Mendonça, CA Len, MTRA Terreri, CHM Silva, RMC Pinto

Evaluation of disease activity in a population of Russian JIA patients

  • Open Access
  • Poster presentation

OM Kostareva, IP Nikishina, SF Erdes, SO Salugina

Chronic exposure to Interleukin-6 amplifies the response to Toll-like receptor ligands: implication on the pathogenesis of macrophage activation syndrome

  • Open Access
  • Poster presentation

Raffaele Strippoli, Francesco Carvello, Roberta Scianaro, Loredana De Pasquale, Marina Vivarelli, Stefania Petrini, Luisa Bracci-Laudiero, Fabrizio De Benedetti

Fulminate mycoplasma infection and severe cutaneous vasculitis: an unusual presentation of complete MBL deficiency

  • Open Access
  • Poster presentation

Despoina Maritsi, M Al-Obadi, Alexandra Tabor, PA Brogan

A year in the life of the streptococcus

  • Open Access
  • Poster presentation

ET Mosley, AM McMahon, F Shackley, C Waruiru

Involvement of the heart in Kawasaki Disease: not always coronaritis

  • Open Access
  • Poster presentation

MC Pellegrin, A Taddio, N Giurici, L Lepore, A Ventura

CACP syndrome (Camptodactyly Arthropathy Coxa Vara Pericarditis). Clinical case

  • Open Access
  • Poster presentation

E Košková, E Vrtíková

Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience

  • Open Access
  • Poster presentation

EL Boulter, D Eleftheriou, NJ Sebire, C Edelsten, PA Brogan

Artherial thrombosis with antiphospholipid syndrome in 17 year old female patient: case of familial antiphospholipid syndrome

  • Open Access
  • Poster presentation

M Vidović, S Dobrota, D Perkov, Lj Banfić, K Putarek, K Starčević, M Jelušić-Dražić

Risk of latent tuberculosis in at-risk children with rheumatic diseases

  • Open Access
  • Poster presentation

SC Lim, JE Munro, RC Allen, N Curtis, JD Akikusa

Infliximab in the treatment of refractory uveitis. Does dose really matter?

  • Open Access
  • Poster presentation

MD Sukesh Sukumaran, MD Katherine Marzan, MD Andreas Reiff

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

  • Open Access
  • Poster presentation

G Simonini, A Taddio, M Cattalini, R Caputo, C DeLibero, I Pagnini, S Naviglio, L Lepore, R Cimaz

The Guadalajara-Camptodactyly Syndrome-an unusual case

  • Open Access
  • Poster presentation

RP Khubchandani, RP Hasija, M Dewoolkar

Suptypes of JIA have different susceptibility for developing pain amplification syndrome

  • Open Access
  • Poster presentation

N Draheim, J Reckzeh, L Croce, R Häfner, E Schnöbel-Müller, JP Haas

Epidemiology of uveitis in children over a 10 years period

  • Open Access
  • Poster presentation

Lydia Clarke, Yan Guex-Crosier, Michael Hofer

A case of pachydermodactyly in a 16 year-old male

  • Open Access
  • Poster presentation

J Madruga Dias, M Manuela Costa, J Romeu, L Soares de Almeida, P Filipe, JA Pereira da Silva

Are growing pains a parasomnia?

  • Open Access
  • Poster presentation

F Aeschlimann, H Werner, O Jenni, RK Saurenmann

Lethal chickenpox infection during treatment with infliximab and methotrexate

  • Open Access
  • Poster presentation

A Estmann, P Toftedal, AJ Schou

Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis

  • Open Access
  • Poster presentation

G Simonini, P Paudyal, G Jones, R Cimaz, GJ Macfarlane

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

AJ Schou, P Toftedal, AE Christensen

Autoantibodies frequency in children with visceral leishmaniosis

  • Open Access
  • Poster presentation

Luciana Marques, Raquel Lisboa, Romana Maia

Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)

  • Open Access
  • Poster presentation

MD Yepez Ricardo, MD Malagon Clara, Consuelo Romero-Sanchez, MD Mosquera Catalina

Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy

  • Open Access
  • Poster presentation

G Dueckers, K Siepermann, G Ganser, S Hardt, M Wennmacher, AE Horwitz, C Haneke, T Niehues

Manifestation of connective tissue diseases (CTD) in pediatrics patients with autoimmune hepatitis (AIH)

  • Open Access
  • Poster presentation

S Garay, M Mastri, A Besga, M Fabi, T Gonzalez Villar

Septic sacroiliitis in children-a diagnostic challenge

  • Open Access
  • Poster presentation

N Scotti, G Russo, R Carlomagno, C Forni, F Orlando, MG Della Casa, M Alessio

Raynaud's phenomenon in pediatric age

  • Open Access
  • Poster presentation

M Tavares, A Novo, H Sousa, I Silva, I Almeida, M Guedes

Various aspects of Kikuchi disease in three children: systemic or self-limited disease?

  • Open Access
  • Poster presentation

L Goffin, S Huybrechts, C Heijmans, AS Bouteiller, C Thomée, V Segers, MF Dehou, A Ferster

Predictive clinical and hematological factors in the differential diagnosis between malignancy and arthritis in children: a case-control study

  • Open Access
  • Poster presentation

Cristina Trigilia, Martina Barchitta, Tiziana Timpanaro, Silvia Marino, Rosaria Garozzo, Manuela La Rosa, Giovanna Russo, Antonella Agodi, Patrizia Barone, Andrea Di Cataldo

Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology

  • Open Access
  • Poster presentation

Daniel B Hawcutt, Clare Pain, Rachel Mulholland, Lisa M Cann, Gavin Cleary, Michael W Beresford, Eileen Baildam

Complementary and alternative medicine (CAM) in pediatric rheumatology: an European perspective

  • Open Access
  • Poster presentation

G Fadanelli, F Vittadello, G Martini, ME Zannin, G Zanon, F Zulian

Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome

  • Open Access
  • Poster presentation

Jan-Inge Henter, AnnaCarin Horne, Bo Magnusson, Stefan Hagelberg

Evaluation of hypermobility syndrome associated with vesico-ureteric reflux in children

  • Open Access
  • Poster presentation

Reza Shiari, Reza Amir Askari, Masumeh Mohkam

Systemic Lupus Erythematosus complicated by Neuromyelitis Optica (Devic’s Syndrome): case series from a single paediatric rheumatology centre

  • Open Access
  • Poster presentation

Despoina Maritsi, Muthana Al-Obadi, Sonia Melo-Gomes, Kjell Tullus, Clarissa A Pilkington

Hematological features in children with systemic lupus erythematosus: are they more common than appreciated?

  • Open Access
  • Poster presentation

Muge Gokce, Nesrin Besbas, Yelda Bilginer, Mualla Cetin, Fatma Gumruk, Seza Ozen

FDG-PET in juvenile systemic lupus erythematosus

  • Open Access
  • Poster presentation

M Alberdi, A Jørgensen, I Law, S Nielsen, MB Jørgensen

A Greek multicenter study comparing the clinical and immunologic phenotypes between adult and juvenile- onset lupus

  • Open Access
  • Poster presentation

P Nalbanti, S Stefanidou, S Alfantaki, A Siamopoulou, M Trachana, V Galanopoulou, P Pratsidou-Gerts, E Farmaki, F Papachristou, A Garyphallos, F Kanakoudi-Tsakalidou

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece

  • Open Access
  • Poster presentation

M Trachana, A Koutsonikoli, E Farmaki, N Printza, V Tzimouli, F Papachristou

Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE)

  • Open Access
  • Poster presentation

Joshua Pendl, Matt Hollander, Shannen Nelson, Wajeeha Yousaf, Nicola Ruperto, Michael Beresford, Marisa Klein-Gitelman, Marilynn Punaro, Anne Stevens, Tadej Avcin, Graciela Espada, Tsz-Leung Lee, Yu-Lung Lau, Jennifer Huggins, Esi Morgan-DeWitt, Hermine I Brunner

Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?

  • Open Access
  • Poster presentation

C Jurado, B Bader-Meunier, B Ranchin, S Decramer, M Fischbac, E Bérard, F Saint-Marcoux

A case of generalized psoriasis-like skin lesions caused by rituximab use in a 14-years patient with systemic lupus erythematosus

  • Open Access
  • Poster presentation

SR Rodionovskaya, IP Nikishina, IN Tsymbal, IN Lavrentieva

Two different cases of SLE with neuropsychiatric manifestation

  • Open Access
  • Poster presentation

V Panaviene, S Rusoniene, M Jakutovic

Cross-sectional evaluation of bone mass in young adults with Juvenile Onset Systemic Lupus Erythematosus: the role of bone mass determinants in a large cohort of patients

  • Open Access
  • Poster presentation

Falcini Fernanda, Stagi Stefano, Cavalli Loredana, Capannini Serena, Masi Laura, Ceri Lorenzo, Denaro Valentina, Matucci Cerinic Marco, Brandi Maria Luisa

Acute adrenal failure (AAF) as the presenting symptom of primary antiphospholipid syndrome (APS)

  • Open Access
  • Poster presentation

G Russo, R Carlomagno, C Forni, L De Martino, D Capalbo, M Alessio

Bone mineral density in patients with juvenile systemic lupus erythematosus

  • Open Access
  • Poster presentation

Ana Paula Roenick Guenka, Blanca Bica, Laura Mendonça, Lucas Velloso, Mario Leitão

Liver involvement in juvenile systemic lupus erythematosus (SLE)

  • Open Access
  • Poster presentation

Generosa Mariniello, Giustina Russo, Raffaella Carlomagno, Rosalba Vitale, Maria Alessio

Penile anthropometry in adolescents and adults systemic lupus erythematosus

  • Open Access
  • Poster presentation

Ana P Vecchi, Eduardo F Borba, Eloísa Bonfá, Marcelo Cocuzza, Patrícia Pieri, Chong A Kim, Clovis A Silva

Systemic lupus erythematosus in Saudi children: Long-term outcome

  • Open Access
  • Poster presentation

Sulaiman M Al-Mayouf

Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study

  • Open Access
  • Poster presentation

P Miettunen, A Pistorio, A Ravelli, S Oliveira, M Alessio, R Cuttica, D Mihaylova, G Espada, S Pasic, E Cortis, S Ozen, O Porras, F Sztajnbok, E Palmisani, A Martini, N Ruperto

Plasmapheresis and Cyclophosphamide therapy in an eight year old girl with cerebral manifestation of systemic lupus erythematodes

  • Open Access
  • Poster presentation

A Ulbrich, I Lanator, D Csaicsich, MT Schmook, R Seidl, W Emminger

Biventricular systolic and diastolic function in a cohort of juvenile-onset systemic lupus erythematosus patients

  • Open Access
  • Poster presentation

Mariana Rodrigues, Luzia Sampaio, Cláudia Moura, Patrícia Costa, Iva Brito

Traditional cardiovascular risk factors in a cohort of juvenile-onset systemic lupus erythematosus (J-SLE)

  • Open Access
  • Poster presentation

Mariana Rodrigues, Luzia Sampaio, Cláudia Moura, Patrícia Costa, Iva Brito

Identification of predictors of bone mineral density trajectories in pediatric Systemic Lupus Erythematosus patients

  • Open Access
  • Poster presentation

SHL Lim, SM Benseler, PN Tyrrell, M Charron, ED Silverman

Infantile de novo primary antiphospholipid syndrome revealed by neonatal stroke

  • Open Access
  • Poster presentation

E Merlin, E Doré, S Chabrier, A Marques Verdier, JL Stéphan

Neuropsychiatric lupus in children

  • Open Access
  • Poster presentation

P Costa Reis, S Nativ, J Isgro, C Yildirim-Toruner, L Imundo, A Eichenfield

Age related clinical presentation and laboratory parameters in juvenile SLE: a Hungarian multicenter study

  • Open Access
  • Poster presentation

B Derfalvi, A Malik, M Kreko, K Pasti, T Tarr, G Marton, Zs Gyorke, B Mosdosi, Z Nyul, J Noll, I Csurke, F Harangi, Zs Balogh, I Orban, K Sevcic, E Kiss, R Kaposzta, B Szucs, S Turi, P Sallay, Gy Reusz, T Tulassay, AJ Szabo

Pediatric systemic lupus erythematosus and human parvovirus B19 infection

  • Open Access
  • Poster presentation

V Bélien-Pallet, S Sauvion, R Salomon, P Quartier, B Bader-Meunier

Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE)

  • Open Access
  • Poster presentation

Cláudia Goldenstein-Schainberg, Ana P Nascimento, André LS Hayata, Eloisa Bonfá

Pathologic motion patterns in patients with progressive pseudorheumatoid arthropathy of childhood

  • Open Access
  • Poster presentation

M Hartmann, F Kreuzpointner, R Haefner, J-P Haas

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis

  • Open Access
  • Poster presentation

I Orbán, K Sevcic, EV Kiss

Usefulness of MRI in the follow-up of ERA-related sacroiliitis, and effectiveness of treatment with sulphasalazine

  • Open Access
  • Poster presentation

Ilaria Pagnini, Gabriele Simonini, Teresa Giani, Sara Savelli, Claudio Fonda, Rolando Cimaz

Transfer-consultations for young people: how do we do?

  • Open Access
  • Poster presentation

G Teilmann, K Boisen, J Pødenphant, M Zak, S Nielsen

Current attitude of rheumatology practitioners on transition and transfer from pediatric to adult health care

  • Open Access
  • Poster presentation

Deborah Hilderson, Philip Moons, Rene Westhovens, Carine Wouters

CLARITY: C hiL dhood A rthritis R isk Factor I dentification ST udY. Investigating the role of aberrant DNA methylation in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

JA Ellis, R Chavez, L Gordon, AL Ponsonby, B Lim, J Akikusa, R Allen, R Saffery, J Craig, JE Munro

Clinical heterogeneity among a three-generation Japanese family with D18N TREX1 mutation for Aicardi-Goutières syndrome / familial chilblain lupus

  • Open Access
  • Poster presentation

J Abe, R Nishikomori, K Izawa, T Awaya, T Kawai, T Yasumi, T Heike, N Hiragi, T Hiragi

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment

  • Open Access
  • Poster presentation

J Vojinovic, G Susic, D Lazarevic, J Basic, I Nikolic, N Damjanov

Differential expression of transcription factors predicted to regulate angiopoietin-1 and -2 genes is associated with specific angiopoietin signatures in RA and PsA synovial tissue

  • Open Access
  • Poster presentation

M Frleta, LGM van Baarsen, S Garcia-Perez, D de Launay, M Garrelfs, DM Gerlag, PP Tak, KA Reedquist

PD-1/PD-L1 signaling in JIA synovial regulatory T cell function

  • Open Access
  • Poster presentation

Sytze de Roock, Genoveva Keustermans, Chantal L Duurland, Ellen JM Wehrens, Femke van Wijk, Berent J Prakken

Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function

  • Open Access
  • Poster presentation

Femke Van Wijk, E Wehrens, C Duurland, B Vastert, M Klein, J Meerding, W De Jager, B Prakken

Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)

  • Open Access
  • Poster presentation

A Hinks, J Cobb, P Martin, E Flynn, S Eyre, J Packham, A Barton, J Worthington, W Thomson

Association of the polymorphisms P53 gene with juvenile idiopathic arthritis in children Russian Fedration

  • Open Access
  • Poster presentation

Alexey N Kozhevnikov, Michael V Moskalenko, Nina A Pozdeeva, Margarita F Dubko, Valentina I Larionova, Gennagy A Novik

Phenotypic variation in familial chilblain lupus (FCL) and Aicardi-Goutières syndrome (AGS) associated with TREX1 mutation in 4 family members

  • Open Access
  • Poster presentation

James Glanville, Saleem Taibjee, Yanick Crow, Penny Davis, Clive Ryder, Taunton Southwood

Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort

  • Open Access
  • Poster presentation

J Cobb, A Hinks, P Martin, E Flynn, R Carrasco, E Baildam, H Foster, J Gardner-Medwin, A Chieng, L Wedderburn, J Davidson, K Hyrich, W Thomson

B cell subsets phenotype in autoimmunity with immunodeficiency: analysis of a cohort of patients with APECED syndrome

  • Open Access
  • Poster presentation

A Magnani, A Meloni, M Gattorno, A Martini, E Traggiai

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

THCM Reinards, HM Albers, DMC Brinkman, SSM Kamphuis, MAJ van Rossum, EPAH Hoppenreijs, HJ Girschick, C Wouters, RK Saurenmann, JJ Houwing-Duistermaat, REM Toes, TWJ Huizinga, R ten Cate, MW Schilham

Association of the CCR5 Δ32 variant with juvenile idiopathic arthritis in a meta-analysis

  • Open Access
  • Poster presentation

THCM Reinards, HM Albers, DMC Brinkman, SSM Kamphuis, MAJ van Rossum, EPAH Hoppenreijs, HJ Girschick, C Wouters, RK Saurenmann, JJ Houwing-Duistermaat, REM Toes, TWJ Huizinga, R ten Cate, MW Schilham

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile

  • Open Access
  • Poster presentation

AM Pesenacker, Stavroula Zavitsanou, Kiran Nistala, Lucy R Wedderburn

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus

  • Open Access
  • Poster presentation

Kim Ohl, Ralph Lippe, Eva Verjans, Nora Honke, Karin Maschke-Neuss, Norbert Wagner, Johannes Roth, Klaus Tenbrock

The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases

  • Open Access
  • Poster presentation

Olga Klochkova, Leila Namazova-Baranova, Ekaterina Alekseeva, Olga Kozhevnikova

NOD2/CARD 15 gene mutations in patients with Familial Mediterranean Fever

  • Open Access
  • Poster presentation

Y Berkun, A Karban, S Padeh, Y Shinar, E Pras, M Lidar, A Livneh, Y Bujanover

Diagnosis of NLRP3 somatic mosaicism in CINCA/NOMID patients using next-generation sequencing

  • Open Access
  • Poster presentation

K Izawa, R Nishikomori, N Tanikaze, MK Saito, R Goldbach-Mansky, I Aksentijevich, T Yasumi, T Kawai, T Nakahata, T Heike, O Ohara

Emperipolesis and cell death in NOD2-related Blau Syndrome and Crohn’s disease

  • Open Access
  • Poster presentation

Carl EI Janssen, Carlos D Rose, Antonio Naranjo, Brigitte Bader-Meunier, Rolando Cimaz, Miroslav Harjacek, Pierre Quartier, Rebecca TenCate, Caroline Thomee, Isabelle Cleynen, Tammy M Martin, Gert De Hertogh, Tania Roskams, Valeer J Desmet, Carine H Wouters

Granuloma-in-follicles in pediatric Crohn’s disease

  • Open Access
  • Poster presentation

Carl EI Janssen, Isabelle Cleynen, Gert De Hertogh, Valeer J Desmet, Tania Roskams, Carine H Wouters

The role of Inositol 1,4,5 triphosphate kinase C in the pathogenesis of Kawasaki disease

  • Open Access
  • Poster presentation

Vahid Khajoee, Rae SM Yeung

Oxidant and antioxidant status in children with juvenile idiopathic athritis

  • Open Access
  • Poster presentation

Hakan M Poyrazoglu, Ikbal Gökçek, Cevat Yazici, Ruhan Düsünsel, Zübeyde Gündüz, Ismail Dursun

PFAPA syndrome is linked to dysregulated IL-1β production

  • Open Access
  • Poster presentation

Laeticia Kolly, Annette von Scheven-Gete, Nathalie Busso, Nathaliane Bagnoud, Dirk Holzinger, Michael Morris, Michael Hofer

A validation of diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in Turkish children

  • Open Access
  • Poster presentation

Erkan Demirkaya, Cengizhan Acikel, Isabella Ceccherini, Seza Özen, Abdulbaki Karaoglu, Ismail Dursun, Betul Sozeri, Yelda Bilginer, Zubeyde Gunduz, Yusuf Tunca, Katerina Oikonomaki, Ioanna Varela, Francesco Caroli, Maria Pia Sormani, Marco Gattorno

Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?

  • Open Access
  • Poster presentation

L Lamot, LT Bukovac, F Borovecki, K Vlahovicek, S Sumic, K Gotovac, F Bingula, M Harjacek

Novel mutation of the LPIN2 gene in Turkish brothers with Majeed syndrome. Response to IL-1 inhibition

  • Open Access
  • Poster presentation

T Herlin, M Bjerre, B Fiirgaard, G Kerndrup, H Hasle, P Ferguson

Prevalence of MEFV gene mutations in apparently healthy Slovenian and Macedonian population

  • Open Access
  • Poster presentation

M Debeljak, N Abazi, N Toplak, K Stavrić, M Kolnik, D Kuzmanovska, T Avčin

Impact of MEFV genotype in Caucasian children with periodic fever

  • Open Access
  • Poster presentation

Silvia Federici, G Calcagno, Martina Finetti, Romina Gallizzi, Antonella Meini, A Vitale, F Caroli, M Cattalini, Roberta Caorsi, Francesco Zulian, Alberto Tomasini, A Insalaco, J Frenkel, Mariapia Sormani, M Baldi, Isabella Ceccherini, Alberto Martini, Marco Gattorno

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment

  • Open Access
  • Poster presentation

N Toplak, J Frenkel, S Ozen, F De Benedetti, M Hofer, I Kone-Paut, H Girschick, B Neven, H Ozdogan, J Kummerle-Deschner, J Arostegui, A Simon, S Stojanov, R Vesely, C Wouters, V Hentgen, C Rose, P Dolezalova, H Lachmann, P Woo, I Touitou, A Martini, N Ruperto, M Gattorno

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease

  • Open Access
  • Poster presentation

L Cantarini, MG Brizi, G Simonini, T Giani, A Vitale, A Fioravanti, MR Bacarelli, M Galeazzi, R Cimaz

Significance of I313V mutation of NLPR3 gene in two pediatric patients

  • Open Access
  • Poster presentation

A Omenetti, R Antona, R Gallizzi, M Alessio, M Finetti, S Carta, A Rubartelli, A Martini, M Gattorno

Diversity in clinical manifestations of autoinflammatory syndromes

  • Open Access
  • Poster presentation

S Boiu, B Neven, S Compeyrot-Lacassagne, R Mouy, B Bader-Meunier, P Quartier

Deregulation of IL-1β axis in peripheral blood mononuclear cells from patients with Chronic Recurrent Multifocal Osteomyelitis

  • Open Access
  • Poster presentation

Roberta Scianaro, Antonella Insalaco, Giusi Prencipe, Luisa Bracci-Laudiero, Anna Maria Teti, Fabrizio De Benedetti

Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ?

  • Open Access
  • Poster presentation

B Bader-Meunier, S Fraitag, CEI Janssen, G de Saint Basile, K Brochard, N Brousse, C Bodemer, C Wouters

Evaluation of immune suppressive mechanisms in a murine model of familial hemophagocytic lymphohistiocytosis

  • Open Access
  • Poster presentation

Stéphanie Humblet-Baron, Adrian Liston

Genetic polymorphism of COL1A1 gene and bone mineralisation in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

MM Kostik, GS Demin, GV Stoyko, LA Scheplyagina, VI Larionova

Decreased osteoblastogenesis from synovial fluid progenitors as a marker of systemic inflammatory process in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

E Lazic Mosler, M Jelusic-Drazic, D Grcevic, A Marusic, N Kovacic

Rothmund-Thomson syndrome: Immuno-osseous challenges

  • Open Access
  • Poster presentation

I Meyts, L De Somer, X Bossuyt, M-A Morren, K Devriendt, C Wouters

Shwachman-Diamond Syndrome: frequent misdiagnosis as Jeune Syndrome and other peculiarities

  • Open Access
  • Poster presentation

I Meyts, H Schaballie, F Haerynck, L Sevenants, C Vermylen, V Bordon, X Bossuyt, A Corveleyn, A Uyttebroeck, M Renard

Peripheral joint ankylosis in the spontaneous model of arthritis in DBA/1 mice is genetically associated with BMP signaling

  • Open Access
  • Poster presentation

S Carter, I Derese, K Braem, AM Valdes, FP Luyten, RJ Lories

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

L Cantarini, MG Brizi, G Simonini, T Giani, A Vitale, A Fioravanti, MR Bacarelli, Galeazzi Mauro, R Cimaz

Great expectations

  • Open Access
  • Poster presentation

Noora Paruys

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis

  • Open Access
  • Poster presentation

R Joos, C Wouters, J Dehoorne, D Elewaut

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Von einer Mandelallergie, die keine mehr war

Ein zweijähriger Junge mit bekannter Mandelallergie und auffälligen Reaktionen auf Mückenstiche soll auf weitere Allergien getestet werden – eigentlich ein klarer Fall. Doch ein unerwartet erhöhter Tryptase-Wert lässt den Kinderpneumologen aufhorchen. Was steckt hinter diesem Laborergebnis?

Konjunktivaler Provokationstest gelingt leicht in der Praxis

Die aktualisierte S2k-Leitlinie zur Provokationstestung bei allergischen oberen Atemwegserkrankungen steht kurz vor der Verabschiedung. Hinzugekommen ist nun auch die konjunktivale Provokation.

Unkontrolliertes Asthma: Welches Biologikum beim Kind?

Bevor ein Kind mit unkontrolliertem Asthma ein Biologikum erhält, muss zunächst klar sein, dass die Diagnose stimmt. Die Auswahl hängt dann nicht nur vom Zulassungsstatus ab, sondern auch vom jeweiligen Asthma-Phänotyp.

Knoten im Blasenkatheter – und jetzt?

Einem sechsjährigen Jungen wird aufgrund einer operativen Korrektur einer Hypospadie ein Blasenkatheter gelegt. Zehn Tage später soll der Katheter entfernt werden – doch er sitzt fest. So löste das Team das Problem.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Mandeln in und neben einem Holzschälchen/© onairjiw / Getty Images / iStock (Symbolbild), Kind erhält Augentropfen/© Nadzeya Haroshka / Getty Images / iStock (Symbolbild mit Fotomodell), Kind benutzt Inhalator gegen Asthma/© M. Dykstra / Fotolia (Symbolbild mit Fotomodell), Urinkatheter/© Sherry Young / stock.adobe.com